Screening for diabetes: Is it warranted?

Clinica Chimica Acta

Volumn 315, Issue 1-2, 2002, Pages 61-69

  Greenberg, Roger A ^a   Sacks, David B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Diabetes; Glycohemoglobin; Hb A1c; Screening

Indexed keywords

AUTOANTIBODY; HEMOGLOBIN A1C;

CORONARY ARTERY DISEASE; ECONOMIC ASPECT; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY TEST; MORBIDITY; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RETINOPATHY; REVIEW; SCREENING; STROKE;

BLOOD GLUCOSE; CIRCADIAN RHYTHM; CLINICAL TRIALS; DIABETES MELLITUS, TYPE 2; EVIDENCE-BASED MEDICINE; FASTING; GLUCOSE TOLERANCE TEST; GUIDELINES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MASS SCREENING; MIDDLE AGED; MULTIPHASIC SCREENING; SENSITIVITY AND SPECIFICITY;

EID: 0036133171     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(01)00722-7     Document Type: Review

References (43)

1. Type-I diabetes: A chronic autoimmune disease of human, mouse, and rat
2. Role of insulin resistance in human disease
3. The pathogenesis of type II diabetes mellitus: A polygenic disease
4. Summary and recommendations of the Fourth International Workshop - Conference on Gestational Diabetes Mellitus
5. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
6. Report of the expert committee on the diagnosis and classification of diabetes mellitus
7. Undiagnosed NIDDM: Clinical and public health issues
8. Onset of NIDDM occurs at least 4-7 yr. before clinical diagnosis
9. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
10. Diabetes trends in the U.S.: 1990-1998
11. The continuing increase of diabetes in the US
12. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections
13. Obesity as a medical problem
14. Economic costs of obesity and inactivity
15. Obesity - What are the current treatment options?
16. The spread of the obesity epidemic in the United States, 1991-1998
17. Long-term complications of diabetes mellitus
18. United Kingdom prospective diabetes study (UKPDS): What now or so what?
19. Economic consequences of diabetes mellitus in the U.S. in 1997
20. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
21. Tests of glycemia in diabetes
22. Definition, diagnosis and classification of diabetes mellitus and its complications: Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation
23. Screening for diabetes
24. Effectiveness of sodium fluoride as a preservative of glucose in blood
25. Accuracy of plasma glucose measurements in the hypoglycemic range
26. Insulin and glucose responses to identical oral glucose tolerance tests performed 48 hours apart
27. Diurnal variation in fasting plasma glucose: Implications for diagnosis of diabetes in patients examined in the afternoon
28. Implications of the revised criteria for diagnosis and classification of diabetes mellitus
29. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: The Hoorn Study
30. Comparison of diabetes diagnostic categories in the U.S.population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria
31. 1c) in screening for undiagnosed diabetes in the U.S. population
32. Relationship between fasting plasma glucose and glycosylated hemoglobin: Potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria
33. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin
34. Worldwide increase in incidence of Type I diabetes - The analysis of the data on published incidence trends
35. Crucial points at diagnosis. Type 2 diabetes or slow type diabetes
36. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64 K autoantibody positivity at onset predicts diabetes type
37. Immunology in diabetes: An update
38. Prediction of type I diabetes in first-degree relatives using a combination of insulin GAD, and ICA512bdc/IA-2autoantibodies
39. Proposed guidelines on screening for risk of type 1 diabetes. Immunology of Diabetes Society
40. The Diabetes Prevention Trial Type 1 diabetes (DPT-1): Implementation of screening and staging of relatives
41. Candidate reference methods for hemoglobin A1c based on peptide mapping